Ursula von der Leyen, president of the European Commission (John Thys, Pool via AP)

Covid-19 roundup: Eu­ro­pean Com­mis­sion pre­pares to sue for As­traZeneca dos­es — re­port; NIH adds poly­clon­al an­ti­body to AC­TIV-2 tri­al

The Eu­ro­pean Com­mis­sion wants the vac­cine dos­es that As­traZeneca pledged to the bloc — and it’s will­ing to launch le­gal pro­ceed­ings to get them, ac­cord­ing to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.